TITLE

A New Approach to the Treatment of Metastatic Paraganglioma: Sorafenib

AUTHOR(S)
Gunaldi, Meral; Kara, Ismail Oguz; Duman, Berna Bozkurt; Afsar, Cigdem Usul; Ergin, Melek; Avci, Arbil
PUB. DATE
October 2014
SOURCE
Cancer Research & Treatment;2014, Vol. 46 Issue 4, p411
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Paragangliomas are relatively rare chromaffin cell tumors which may be cured through resection. Patients with paragangliomas may develop metastatic diseases. There is no consensus regarding refractory chemotherapy for treatment of metastatic disease. In this report, we presented a case of a 43-year-old woman who was admitted to the hospital with a history of episodic headaches, diaphoresis, and weakness. Elevated plasma catecholamine levels and a right paraaortic mass were observed on computed tomography. The mass was excised, and a diagnosis of paraganglioma was confirmed. After 20 months of follow-up, local recurrence and metastases were detected in the thorax, abdomen, and skeletal system. Plasma and urinary catecholamine levels were high. Chemotherapy was administered, and no improvement was observed. Therefore, following this palliative conventional chemotherapy, sorafenib was administered for three months, and, finally, positron emission tomography showed that the patient's lesions had completely regressed.
ACCESSION #
98855005

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics